New York, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The global subdermal contraceptive implants market size is slated to expand at ~9% CAGR between 2024 and 2036. The market is poised to garner a revenue of ...

Report Ocean presents a new report on subdermal contraceptive implants market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for ...

Vivani Medical, Inc. (NASDAQ:VANI), on Wednesday, released preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic weight management in obese and overweight ...

“Marketresearch.biz reports that the Subdermal Contraceptive Implants Market presents growth opportunities through expanding awareness campaigns and continuous technological advancements, catering to ...

April 26, 2010 (Barcelona, Spain) — The gonadotropin-releasing hormone (GnRH) agonist histrelin acetate (VantasR), administered as a 50 mg subdermal implant once yearly, retained its effectiveness ...

A novel, subdermal implant delivering potent antiretroviral drugs shows extreme promise in stopping the spread of HIV, researchers report. Scientists say that they have developed a matchstick size ...

A year after the FDA rejected Titan Pharmaceutical's ($TTNP) Probuphine subdermal implant for the treatment of opioid dependence, the company is knocking on the ...

In modern times, a portable storage device isn't far from our possession. Either we can use the storage on our phones or tablets, or we keep a small flash drive on a keychain. Accessing the data, ...